Atria Wealth Solutions’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$937K Sell
2,984
-454
-13% -$136K 0.02% 664
2025
Q1
$1.05M Sell
3,438
-129
-4% -$43.4K 0.01% 867
2024
Q4
$1.19M Sell
3,567
-279
-7% -$94.6K 0.01% 862
2024
Q3
$1.28M Sell
3,846
-2,557
-40% -$971K 0.01% 824
2024
Q2
$2.64M Buy
6,403
+1,089
+20% +$431K 0.03% 541
2024
Q1
$2.15M Sell
5,314
-40
-0.7% -$14.1K 0.02% 611
2023
Q4
$1.64M Buy
5,354
+785
+17% +$212K 0.02% 669
2023
Q3
$1.11M Buy
4,569
+480
+12% +$123K 0.02% 765
2023
Q2
$982K Sell
4,089
-1,280
-24% -$266K 0.01% 837
2023
Q1
$1.01M Sell
5,369
-3,189
-37% -$660K 0.01% 793
2022
Q4
$1.82M Sell
8,558
-1,605
-16% -$321K 0.03% 551
2022
Q3
$1.6M Buy
+10,163
New +$1.62M 0.03% 558

Other funds holding MEDP

Atria Wealth Solutions's MEDP Position: Q2 2025 in Review

Atria Wealth Solutions reduced its Medpace (MEDP) stake by 13% in Q2 2025, selling an estimated $136K and leaving 2,984 shares worth $937K. The position accounts for 0.02% of the portfolio, ranked #664.

Atria Wealth Solutions first reported a position in MEDP in Q3 2022 and has held it in 12 quarters since. The position peaked at $2.64M in Q2 2024. 602 funds tracked by Wall St. Rank hold MEDP as of Q2 2025.

  • Atria Wealth Solutions held 2,984 shares of Medpace worth $937K as of Q2 2025.
  • Atria Wealth Solutions sold 454 Medpace shares in Q2 2025, an estimated $136K.
  • Medpace made up 0.02% of Atria Wealth Solutions's portfolio in Q2 2025, its #664 holding.
  • Atria Wealth Solutions first reported a position in Medpace in Q3 2022 and has held it in 12 quarters since.
  • Atria Wealth Solutions's Medpace position peaked at $2.64M in Q2 2024.
  • 602 funds tracked by Wall St. Rank held Medpace as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.